Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

Dermatomyositis has been modeled as an autoimmune disease largely mediated by the adaptive immune system, including a local humorally mediated response with B and T helper cell muscle infiltration, antibody and complement‐mediated injury of capillaries, and perifascicular atrophy of muscle fibers caused by ischemia. To further understand the pathophysiology of dermatomyositis, we used microarrays, computational methods, immunohistochemistry and electron microscopy to study muscle specimens from 67 patients, 54 with inflammatory myopathies, 14 with dermatomyositis. In dermatomyositis, genes induced by interferon‐α/β were highly overexpressed, and immunohistochemistry for the interferon‐α/β inducible protein MxA showed dense staining of perifascicular, and, sometimes all myofibers in 8/14 patients and on capillaries in 13/14 patients. Of 36 patients with other inflammatory myopathies, 1 patient had faint MxA staining of myofibers and 3 of capillaries. Plasmacytoid dendritic cells, potent CD4+ cellular sources of interferon‐α, are present in substantial numbers in dermatomyositis and may account for most of the cells previously identified as T helper cells. In addition to an adaptive immune response, an innate immune response characterized by plasmacytoid dendritic cell infiltration and interferon‐α/β inducible gene and protein expression may be an important part of the pathogenesis of dermatomyositis, as it appears to be in systemic lupus erythematosus. Ann Neurol 2005;57:664–678

[1]  S. Greenberg,et al.  Uncertainties in the pathogenesis of adult dermatomyositis , 2004, Current opinion in neurology.

[2]  R. Hughes,et al.  119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[3]  G. Borm,et al.  Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[4]  C. Bao,et al.  Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. , 2003, Rheumatology.

[5]  M. Crow Interferon-α: A new target for therapy in systemic lupus erythematosus? , 2003 .

[6]  C. Bao,et al.  Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray , 2003, Genes and Immunity.

[7]  J. Hardin Directing Autoimmunity to Nucleoprotein Particles , 2003, The Journal of experimental medicine.

[8]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[9]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Crow Interferon-alpha: a new target for therapy in systemic lupus erythematosus? , 2003, Arthritis and rheumatism.

[11]  L. Rönnblom,et al.  The natural interferon-α producing cells in systemic lupus erythematosus , 2002 .

[12]  C. Angelini,et al.  Muscle pathology in dysferlin deficiency , 2002, Neuropathology and applied neurobiology.

[13]  L. Kunkel,et al.  Molecular profiles of inflammatory myopathies , 2002, Neurology.

[14]  G. Kochs,et al.  Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity , 2002, Traffic.

[15]  M. McNiven,et al.  The Antiviral Dynamin Family Member, MxA, Tubulates Lipids and Localizes to the Smooth Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.

[16]  Eric P. Hoffman,et al.  Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 , 2002, The Journal of Immunology.

[17]  M. Dalakas,et al.  Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.

[18]  L. Rönnblom,et al.  The natural interferon-alpha producing cells in systemic lupus erythematosus. , 2002, Human immunology.

[19]  L. Rönnblom,et al.  Importance of CpG Dinucleotides in Activation of Natural IFN‐α‐Producing Cells by a Lupus‐Related Oligodeoxynucleotide , 2001, Scandinavian journal of immunology.

[20]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[21]  S. Miltenyi,et al.  BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.

[22]  G. Sturfelt,et al.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.

[23]  S. Goodbourn,et al.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.

[24]  Andrew G. Engel,et al.  αB-Crystallin immunolocalization yields new insights into inclusion body myositis , 2000, Neurology.

[25]  B. Banwell,et al.  AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. , 2000, Neurology.

[26]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[27]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[28]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Magro,et al.  The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus , 1997, Journal of cutaneous pathology.

[30]  I. Illa,et al.  Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. , 1997, The American journal of pathology.

[31]  C. Janeway Immunobiology: The Immune System in Health and Disease , 1996 .

[32]  P. Tempst,et al.  Purification, Microsequencing, and Immunolocalization of p36, a New Interferon-α-induced Protein That Is Associated with Human Lupus Inclusions (*) , 1996, The Journal of Biological Chemistry.

[33]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[34]  R. Steinman,et al.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.

[35]  H. Hochkeppel,et al.  The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. , 1990, AIDS.

[36]  A. Engel,et al.  Immune effector mechanisms in inflammatory myopathies. , 1990, Research publications - Association for Research in Nervous and Mental Disease.

[37]  P. Grimley,et al.  Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2',5' oligoadenylate synthetase induction. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[38]  J. Orenstein,et al.  The relationship of serum alpha-interferon and ultrastructural markers in HIV-seropositive individuals. , 1987, Ultrastructural pathology.

[39]  S. Rich,et al.  Induction of lupus inclusions by sera from patients with systemic lupus erythematosus. , 1986, Arthritis and rheumatism.

[40]  J. Mendell,et al.  Microvascular deposition of complement membrane attack complex in dermatomyositis. , 1986, The New England journal of medicine.

[41]  J. Hoofnagle,et al.  Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[42]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.

[43]  J. Deruaz,et al.  [The pathology of skeletal muscle]. , 1981, Revue medicale de la Suisse romande.

[44]  S. Rich Human lupus inclusions and interferon. , 1981, Science.

[45]  A. Eisen,et al.  Experimental ischemic myopathy. , 1974, Journal of the neurological sciences.

[46]  W. Engel,et al.  Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. , 1970, Archives of neurology.

[47]  W. L. Norton,et al.  Endothelial inclusions in dermatomyositis. , 1970, Annals of the rheumatic diseases.

[48]  Robert G. Cooper,et al.  Polymyositis and Dermatomyositis , 2022 .

[49]  Norton Wl Endothelial inclusions in active lesions of systemic lupus erythematosus. , 1969 .

[50]  W. Norton Endothelial inclusions in active lesions of systemic lupus erythematosus. , 1969, The Journal of laboratory and clinical medicine.